Delhi resident doctors prefer Covishield over indigenous Covaxin in Covid-19 vaccination drive
New Delhi/IBNS: Within hours after Prime Minister Narendra Modi launched the Covid-19 vaccination drive, the resident doctors of Delhi on Saturday preferred to be inoculated with Oxford vaccine, named Covishield in India, over the indigenous Covaxin.
Covid-19 vaccination drive starts in Assam
Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.
PM Modi launches world's biggest Covid-19 vaccination drive in India
New Delhi/IBNS: Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in India, which is one of the worst Novel Coronavirus-hit countries.
PM Modi to launch pan India Covid-19 vaccination drive at 10:30 AM on Saturday
New Delhi/IBNS: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on Jan 16 at 10:30 AM via video conferencing.
PM Modi likely to inaugurate Coronavirus vaccination drive virtually on Jan 16
New Delhi/IBNS: Prime Minister Narendra Modi is likely to inaugurate the coronavirus vaccination drive virtually on January 16, said media reports.
Congress MP Manish Tewari questions roll out of Covaxin
New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.
Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin
Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.
Covid vaccine recipients don't get to choose between two options for now: Centre
New Delhi/IBNS: The Indian government on Tuesday said that no recipient of Covid-19 vaccine gets to choose from the two candidates available in the country for emergency use.
Bharat Biotech announces completion of phase 3 clinical trials of Covid-19 vaccine
New Delhi/UNI: Bharat Biotech on Thursday announced that it has enrolled 25,800 volunteers for phase 3 clinical trials of its indigenously manufactured Covid-19 vaccine, 'Covaxin'.
Covid vaccines to rollout within 10 days from date of authorisation: Centre
New Delhi/IBNS: The Centre on Tuesday informed that Covid-19 vaccines will be ready for rollout in 10 days from the emergency use authorisation date based on feedback from the dry run.
New Delhi/IBNS: Chairman of Bharat Biotech- whose coronavirus vaccine Covaxin has been permitted for "restricted use in an emergency situation in public interest"- on Monday hit out at its critics and said 'don't accuse us of inexperience.'
India registers 18,177 new Covid-19 cases in last 24 hours, 217 deaths
New Delhi/IBNS: India registered 18,177 fresh infections in the last 24 hours taking the total Coronavirus cases to 1,03,23,965 on Sunday, the Union Health Ministry data showed.
Serum Institute, Bharat Biotech get DCGI approval for emergency use of Covid-19 vaccines
New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.
Two Covid-19 vaccine candidates await DCGI approval for emergency use in India
New Delhi/IBNS: Two Covid-19 vaccine candidates in India-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-now awaits the approval of the Drugs Controller General of India (DCGI) for emergency use after they have been cleared by the government-appointed panel.
Expert panel recommends approval for Bharat Biotech's Covaxin
New Delhi/IBNS: A government-appointed panel of experts on Saturday cleared emergency use of indigenous COVID-19 vaccine Covaxin manufactured by Hyderabad-based Bharat Biotech, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).